Scarica l'app Stockscreener
58.54
1.20%
-0.71
Dopo l'orario di chiusura:
58.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vericel Corp Borsa (VCEL) Ultime notizie
SG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Insider Sells $242,256.92 in Stock - MarketBeat
Vericel (NASDAQ:VCEL) Sets New 12-Month HighTime to Buy? - MarketBeat
VCEL Stock Touches 52-Week High at $61.5 Amidst Strong Growth - Investing.com
Park Avenue Securities LLC Takes $280,000 Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Park Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
Vericel (NASDAQ:VCEL) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat
Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World
FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World
FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat
Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN
Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com
Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat
Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
HC Wainwright Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL) - MarketBeat
Beyond The Numbers: 5 Analysts Discuss Vericel Stock - Benzinga
Canaccord reaffirms Vericel stock buy rating on preliminary Q4 results - Investing.com
Vericel's preliminary Q4 revenue falls short of analyst expectations; shares fall 11% post market - Investing.com
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets - Yahoo Finance
Vericel Co. (NASDAQ:VCEL) Receives $61.14 Consensus PT from Analysts - Defense World
JPMorgan Chase & Co. Has $19.08 Million Stake in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 - Yahoo Finance
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $61.14 - MarketBeat
Vericel (NASDAQ:VCEL) Shares Cross Above 200 Day Moving AverageShould You Sell? - MarketBeat
Vericel Corp prices $17 million public offering of common stock - Reuters
5 Best Stem Cell Companies to Invest In (January 2025) - Securities.io
Vericel Co. (NASDAQ:VCEL) Shares Sold by Principal Financial Group Inc. - Defense World
Principal Financial Group Inc. Has $10.64 Million Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
MML Investors Services LLC Raises Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Geode Capital Management LLC Grows Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Geode Capital Management LLC - Defense World
Vericel (NASDAQ:VCEL) Upgraded at StockNews.com - MarketBeat
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Stifel Financial Corp Increases Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Barclays PLC Boosts Stock Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Vericel price target raised to $67 from $61 at Truist - Yahoo Finance
Vericel shares target upgraded, Buy rating on robust growth trajectory - Investing.com
Truist Financial Issues Positive Forecast for Vericel (NASDAQ:VCEL) Stock Price - MarketBeat
Vericel's SWOT analysis: MACI arthro approval boosts cartilage repair stock - Investing.com
Vericel (NASDAQ:VCEL) Shares Up 5.3%Here's What Happened - MarketBeat
TD Cowen lifts Vericel shares target, maintains buy rating on growth prospects - Investing.com
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $59.71 - Defense World
State Street Corp Sells 55,227 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Bioengineered Artificial Skin Market Growth in Future Scope - openPR
Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World
Vericel Co. (NASDAQ:VCEL) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com - Defense World
Wellington Management Group LLP Grows Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 12,375 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel's SWOT analysis: arthroscopic MACI approval boosts stock outlook - Investing.com
BNP Paribas Financial Markets Has $1.35 Million Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Castleark Management LLC Sells 64,040 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):